Decreased biochemical progression in patients with castration‑resistant prostate cancer using a novel mefenamic acid anti‑inflammatory therapy: A randomized controlled trial-Reference-Cited by-同舟云学术

Decreased biochemical progression in patients with castration‑resistant prostate cancer using a novel mefenamic acid anti‑inflammatory therapy: A randomized controlled trial

Published:2020-04-03 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Guzman‑Esquivel Jos�¹,Mendoza‑Hernandez Martha¹,Tiburcio‑Jimenez Daniel¹,Avila‑Zamora Oscar²,Delgado‑Enciso Josuel³,De‑Leon‑Zaragoza Luis⁴,Casarez‑Price Juan⁴,Rodriguez‑Sanchez Iram⁵,Martinez‑Fierro Margarita⁶,Meza‑Robles Carmen¹,Barocio‑Acosta Alejandro²,Baltazar‑Rodriguez Luz¹,Zaizar‑Fregoso Sergio¹,Plata‑Florenzano Jorge⁴,Delgado‑Enciso Iv�n¹

Affiliation:

1. Department of Molecular Medicine, School of Medicine, University of Colima, Colima, Colima 28040, Mexico

2. Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico

3. Department of Research, Foundation for Cancer Ethics, Education and Research of the Cancerology State Institute, Colima 28085, Mexico

4. Department of Research, General Hospital of Zone No. 1 IMSS, Villa de Alvarez, Colima 28983, Mexico

5. Molecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo Le�n, Monterrey, Nuevo Le�n 64460, Mexico

6. Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas, Zacatecas 98160, Mexico

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique;Journal of Cancer Research and Clinical Oncology;2023-11-20

2. The Potential Preventive and Therapeutic Roles of NSAIDs in Prostate Cancer;Cancers;2023-11-16

3. Systemic Inflammation Indices and Association with Prostate Cancer Survival in a Diverse Patient Cohort;Cancers;2023-03-20

4. Meclofenamic acid inhibits the invasion and migration of LNCaP prostate carcinoma cells by regulating vimentin expression;Acta Medica Nicomedia;2022-10-15

5. Investigation of the effect of meclofenamic acid on the proteome of LNCaP cells reveals changes in alternative polyadenylation and splicing machinery;Medical Oncology;2022-09-07